News & Events

Check out our news section to keep up to date with any upcoming events which we will be attending as well as any exciting news within the pharmaceutical industry.

US biotechs driving growth at Scottish CMO

Stirling, UK – STERILE manufacturing specialist Symbiosis Pharmaceutical Services has unveiled a significant surge in demand for its services from US-based biotechnology firms just a year after it expanded its presence into this territory.The fast-growing contract manufacturing organisation (CMO) has picked-up several new clients in North America, which has primarily been driven by companies looking for small scale aseptic manufacturing capabilities to… Read More

Sterile manufacturing specialists strengthens team

Sterile manufacturing expert Symbiosis Pharmaceutical Services has bolstered its project management and manufacturing teams with the appointment of several new staff to support its ongoing growth.The fast-growing contract manufacturing organisation (CMO) has increased employee numbers by around 35% over the last 18 months and expects this to continue in 2016 as the Scotland-based company continues to expand.Symbiosis specialises in the sterile fill/finish of… Read More

UK CMO APPOINTS NEW DIRECTOR

STERILE manufacturing specialist Symbiosis Pharmaceutical Services has appointed Joanne Anderson as its new Business Development Director to help drive its commercial growth.The company has promoted Mrs Anderson to the role following three successful years with the Scotland-based pharmaceutical contract manufacturing organisation (CMO) and will join the management team.Reporting to the CEO, her responsibilities will include the strategic and operational management of all… Read More

Successful sterile inspection for Scottish CMO

Stirling, UK – INJECTABLE manufacturing specialist Symbiosis Pharmaceutical Services has successfully completed a scheduled inspection from the UK Government Regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).The contract manufacturing organisation (CMO) received no critical or major observations and this comes amidst various quality-related issues affecting several other sterile manufacturing sites in the UK and US.Symbiosis has been re-inspected and approved for… Read More

CMO in bulk lyophilisation launch

Stirling, UK – STERILE manufacturing specialist Symbiosis Pharmaceutical Services has unveiled a new bulk lyophilisation (freeze drying) service after winning several new contracts in this niche area.The Scotland-based contract manufacturing organisation (CMO) is supporting clients in the US, Europe and Asia to assist with the manufacture of bulk intermediates and APIs by lyophilisation.Although the company has been providing lyophilisation for the sterile… Read More

It’s all change in Europe’s sterile manufacturing market… or is it?

The last six months has seen some major changes to the sterile manufacturing landscape here in Europe. There have been a number of exits and acquisitions that have no doubt made the market sit up and listen but has anything really changed?At an industry level, the demand for sterile injectable manufacturing capability is evident and industry publications regularly publish indicators of growth… Read More

Gauging Change in Europe’s Sterile Manufacturing Market

Colin MacKay, CEO of Symbiosis Pharmaceutical Services discusses ‘Gauging Change in Europe’s Sterile Manufacturing Market’ in this guest blog as featured on PharmTech.com.The past six months has seen some major changes to the sterile manufacturing landscape in Europe. There have been a number of exits and acquisitions that have no doubt grabbed headlines, but has anything really changed?At an industry level, the… Read More

Symbiosis boosts US presence in response to market growth

UK-based sterile filling specialist Symbiosis Pharmaceutical Services has strengthened its North American footprint with the appointment of a US-based business development manager to support increased demand from biotech companies for its manufacturing services.The move to reinforce Symbiosis’ presence in North America is bolstered by the recent surge in funding of biotech firms in the US. A more positive investor climate in the US continues to… Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.